Bill > SB48

This bill allows students with cystic fibrosis to self-administer their prescribed replacement pancreatic enzymes at school, in addition to the existing provisions that allow students to self-administer medication for asthma and anaphylaxis. The bill requires school districts to adopt policies that permit this self-administration and outlines the necessary steps, such as written parental authorization and a physician's statement confirming the student's capability. The bill also provides liability protections for school districts and employees related to the administration of these medications. The bill takes effect on July 1, 2019 and includes an emergency clause.